NEW YORK (GenomeWeb News) – SQI Diagnostics said today that it had no revenues for its fiscal fourth quarter.

During the year-ago period, the Canadian microarray-based diagnostics development firm recorded C$5,000 (US$5,077), it said in a regulatory filing.

Net loss for the quarter ended Sept. 30 was C$1.7 million, or C$.04 per share, compared to a loss of C$3.9 million, or C$.11 per share, a year ago.